Literature DB >> 35292841

How I do it: endonasal transcribriform approach for resection of esthesioneuroblastoma.

J Curran Henson1, Amarbir Gill2, Jeremiah Alt2, Michael J Karsy3.   

Abstract

BACKGROUND: Olfactory neuroblastoma, also known as esthesioneuroblastoma, accounts for only 3-6% of sinonasal malignancies but confers a 40% 5-year overall survival.
METHOD: The authors describe techniques for the endonasal, minimally invasive resection of an esthesioneuroblastoma in a 69-year-old man who presented with headaches and anosmia and describe surgical nuances and their effect on adjuvant therapy planning.
CONCLUSION: This approach, along with microsurgical techniques, helped increase tumor visualization, improved marginal resection, and reduced surgical risk, which may improve patient outcomes. Multilayered reconstruction with a synthetic dural substitute and creation of a nasoseptal flap were performed to reduce postoperative cerebrospinal fluid leak.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Endoscopic; Esthesioneuroblastoma; Minimally invasive; Olfactory neuroblastoma

Mesh:

Year:  2022        PMID: 35292841     DOI: 10.1007/s00701-022-05178-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.816


  6 in total

Review 1.  Advantages and limitations of endoscopic endonasal approaches to the skull base.

Authors:  Pornthep Kasemsiri; Ricardo L Carrau; Leo F S Ditzel Filho; Daniel M Prevedello; Bradley A Otto; Matthew Old; Danielle de Lara; Amin B Kassam
Journal:  World Neurosurg       Date:  2014-12       Impact factor: 2.104

Review 2.  Translational genomics of sinonasal cancers.

Authors:  Mario A Hermsen; Cristina Riobello; Rocío García-Marín; Virginia N Cabal; Laura Suárez-Fernández; Fernando López; José L Llorente
Journal:  Semin Cancer Biol       Date:  2019-09-24       Impact factor: 15.707

Review 3.  Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.

Authors:  Gautam U Mehta; Shaan M Raza; Shirley Y Su; Ehab Y Hanna; Franco DeMonte
Journal:  J Neurooncol       Date:  2020-05-18       Impact factor: 4.130

4.  The extended direct endonasal transsphenoidal approach for nonadenomatous suprasellar tumors.

Authors:  Joshua R Dusick; Felice Esposito; Daniel F Kelly; Pejman Cohan; Antonio DeSalles; Donald P Becker; Neil A Martin
Journal:  J Neurosurg       Date:  2005-05       Impact factor: 5.115

Review 5.  Esthesioneuroblastoma: A Comprehensive Review of Diagnosis, Management, and Current Treatment Options.

Authors:  Brian Fiani; Syed A Quadri; Alessandra Cathel; Mudassir Farooqui; Anirudh Ramachandran; Imran Siddiqi; Hammad Ghanchi; Atif Zafar; Blake W Berman; Javed Siddiqi
Journal:  World Neurosurg       Date:  2019-03-09       Impact factor: 2.104

Review 6.  Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature.

Authors:  Ahmed S Abdelmeguid; Diana Bell; Diana Roberts; Renata Ferrarotto; Jack Phan; Shirley Y Su; Michael Kupferman; Shaan Raza; Franco DeMonte; Ehab Hanna
Journal:  Laryngoscope       Date:  2021-07-17       Impact factor: 3.325

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.